Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
Top New Articles on HCV
All HCV Articles by Topic ( A to Z )
HCV Basics
HIV-HCV Coinfection
FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
Treatment Guidelines for HCV
Experimental Treatments for HCV
Recent Research Conference Reports
Tests for HCV
Liver-related Complications
Drug-related Adverse Events
Doctor Is In 'Q and A' for HCV
Library of CME Programs
E-mail Update - Sign Up
About Us - Contact Us
_______________
Extrahepatic Events
Fatigue
Adversely Affects Virologic Response to Peginterferon Plus Ribavirin
- 11/21/05
Severe Fatigue
and Age but Not Neurocognitive Dysfunction or Liver Disease Significantly Impair Quality of Life in HCV Patients, Particularly among Women
- 11/04/05
Response to Interferon Alfa Therapy in a Patient with HCV-related Arthritis
- 7/13/05
Extrahepatic
Manifestations in Patients with Chronic Hepatitis C
- 6/20/05
Regression of
Lymphoproliferative Disorders
after Treatment for Hepatitis C Infection
- 3/25/05
Study Shows Increased Risk of
Non-Hodgkin's Lymphoma
and Other
Nonhepatic Malignancies
in Swedish Patients with HCV Infection
- 3/18/05
Relationship Between Serum Ferritin,
Hepatic Iron Staining
, Diabetes Mellitus and Fibrosis Progression in Patients with Chronic Hepatitis C
- 3/9/05
HCV RNA in the
Skin Lesions
of Individuals with Prurigo and Chronic Hepatitis C
- 1/24/05
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US